Literature DB >> 21278491

GPR30 is overexpressed in post-puberal testicular germ cell tumors.

Renato Franco1, Francesca Boscia, Vincenzo Gigantino, Laura Marra, Francesco Esposito, Diana Ferrara, Paolo Pariante, Gerardo Botti, Michele Caraglia, Sergio Minucci, Paolo Chieffi.   

Abstract

GPR30 is a 7-transmembrane G protein-coupled estrogen receptor that functions alongside traditional estrogen receptors to regulate cellular responses to 17β-estradiol and environmental estrogens. In this study, we have evaluated by immunohistochemical analysis GPR30 expression in post-puberal testicular germ cell tumours (30 seminomas, 5 teratomas, 12 embryonal carcinomas, and 20 intratubular germ cell tumors). The GPR30 protein expression was detected at high level in all intratubular germ cell tumours, seminomas, and embryonal carcinomas, whereas in teratomas the expression was low. The immunohistochemical data were further confirmed by Western blot analysis. GPR30 protein expression has also been analyzed in GC1 and TCam-2 cell lines, respectively derived from immortalized type B murine spermatogonia and human seminoma. Our results indicate that GPR30 could be a potential therapeutic target; the design of a specific GPR30 inhibitors could be a useful molecular target to block neoplastic germ cells with a high proliferative rate for the treatment of TGCTs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21278491     DOI: 10.4161/cbt.11.6.14672

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  29 in total

1.  Decline of semen quality among 10 932 males consulting for couple infertility over a 20-year period in Marseille, France.

Authors:  Cendrine Geoffroy-Siraudin; Anderson Dieudonné Loundou; Fanny Romain; Vincent Achard; Blandine Courbière; Marie-Hélène Perrard; Philippe Durand; Marie-Roberte Guichaoua
Journal:  Asian J Androl       Date:  2012-04-23       Impact factor: 3.285

Review 2.  GPER modulators: Opportunity Nox on the heels of a class Akt.

Authors:  Eric R Prossnitz
Journal:  J Steroid Biochem Mol Biol       Date:  2017-03-08       Impact factor: 4.292

3.  An up-date on epigenetic and molecular markers in testicular germ cell tumors.

Authors:  Paolo Chieffi
Journal:  Intractable Rare Dis Res       Date:  2017-11

Review 4.  Recent advances in the biology of germ cell tumors: implications for the diagnosis and treatment.

Authors:  P Chieffi; S Chieffi; R Franco; A A Sinisi
Journal:  J Endocrinol Invest       Date:  2012-11-12       Impact factor: 4.256

Review 5.  International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators.

Authors:  Eric R Prossnitz; Jeffrey B Arterburn
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

6.  17β-estradiol signaling and regulation of Sertoli cell function.

Authors:  Thaís Fg Lucas; Maristela T Pimenta; Raisa Pisolato; Maria Fatima M Lazari; Catarina S Porto
Journal:  Spermatogenesis       Date:  2011-10-01

Review 7.  The G-protein-coupled estrogen receptor GPER in health and disease.

Authors:  Eric R Prossnitz; Matthias Barton
Journal:  Nat Rev Endocrinol       Date:  2011-08-16       Impact factor: 43.330

8.  New perspective on molecular markers as promising therapeutic targets in germ cell tumors.

Authors:  Paolo Chieffi
Journal:  Intractable Rare Dis Res       Date:  2016-05

9.  Expression of the oestrogen receptor GPER by testicular peritubular cells is linked to sexual maturation and male fertility.

Authors:  F Sandner; H Welter; J U Schwarzer; F M Köhn; H F Urbanski; A Mayerhofer
Journal:  Andrology       Date:  2014-07-23       Impact factor: 3.842

10.  Diverse Synaptic Distributions of G Protein-coupled Estrogen Receptor 1 in Monkey Prefrontal Cortex with Aging and Menopause.

Authors:  Johanna L Crimins; Athena Ching-Jung Wang; Frank Yuk; Rishi Puri; William G M Janssen; Yuko Hara; Peter R Rapp; John H Morrison
Journal:  Cereb Cortex       Date:  2017-03-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.